Ignite Creation Date:
2025-12-24 @ 12:44 PM
Ignite Modification Date:
2026-01-02 @ 9:23 AM
Study NCT ID:
NCT01589861
Status:
SUSPENDED
Last Update Posted:
2017-03-28
First Post:
2012-03-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
Sponsor:
Institut Paoli-Calmettes
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PIKHER2/IPC 2011-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None